Position in CERS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,300,000
-$12,271,734 QoQ
Shares Held
2,500,000
-76.8% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#18
of 186 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $637,521,571 across 15 Medical Devices names. CERS ranks #12 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
1,049,000 | $159,710,250 | |
| 2 | NVCR |
NovoCure Ltd
|
9,913,401 | $150,188,025 | |
| 3 | INSP |
Inspire Medical Systems, Inc.
|
1,931,436 | $86,161,359 | |
| 4 | BBNX |
Beta Bionics, Inc.
|
4,393,714 | $68,849,498 | |
| 5 | NPCE |
NeuroPace Inc
|
2,911,122 | $46,257,728 | |
| 6 | GMED |
Globus Medical Inc
|
468,922 | $37,049,527 | |
| 7 | PRCT |
PROCEPT BioRobotics Corp
|
1,003,000 | $22,647,740 | |
| 8 | LIVN |
LivaNova PLC
|
254,957 | $20,965,114 |
All Filings in CERS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,300,000 | 2,500,000 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,571,734 | 10,753,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,240,000 | 4,000,000 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||